The clinical development of cancer therapeutics is a global undertaking, and incorporation
of the patient experience into the clinical decision-making process is of increasing interest to …

Tremendous progress in treatment and outcomes has been achieved across the whole
range of haematological malignancies in the past two decades. Although cure rates for …

Immune checkpoint inhibitor therapies are a novel group of monoclonal antibodies with
proven effectiveness in a wide range of malignancies, including melanoma, renal cell …

Purpose Integrating patient-reported outcomes (PROs) into clinical practice is an
increasingly promising strategy for improving patients' symptoms, communication, and …

In myelodysplastic syndromes (MDS), health-related quality of life (HRQoL) represents a
relevant patient-reported outcome, which is essential in individualized therapy planning …

Head and neck cancer poses a particular challenge in radiation therapy, whilst being an
effective treatment modality it requires very high doses of radiation to provide effective …

Abstract Background/Purpose This study describes late bowel morbidity prospectively
assessed in the multi-institutional EMBRACE study on MRI-guided adaptive brachytherapy …

Purpose The US National Cancer Institute (NCI) Patient-Reported Outcomes version of the
Common Terminology Criteria for Adverse Events (PRO-CTCAE) was developed to enable …

There has recently been an increasing interest in model-based evaluation and comparison
of different treatment options in radiation oncology studies. This is partly driven by the …

Chemoradiotherapy is the primary treatment for patients with squamous cell carcinoma of
the anus, but variations in the reported outcomes have restricted between-study …